letrozole has been researched along with Genital Neoplasms, Female in 2 studies
Genital Neoplasms, Female: Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).
| Excerpt | Relevance | Reference |
|---|---|---|
| " One phase II trial of the potent orally bioavailable mTOR inhibitor, everolimus, in combination with letrozole demonstrated an unprecedented clinical benefit rate (CBR) of 40% and high objective response rate (RR) of 32% in hormone agnostic endometrial cancers." | 2.82 | Targeting the PI3K Pathway in Gynecologic Malignancies. ( Avila, M; Grinsfelder, MO; Pham, M; Westin, SN, 2022) |
| "Metformin is an affordable and well-tolerated drug used in type 2 diabetes." | 1.56 | Metformin in Gynecologic Cancers: Opening a New Window for Prevention and Treatment? ( Goodwin, PJ; Madariaga, A; Oza, AM, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avila, M | 3 |
| Grinsfelder, MO | 3 |
| Pham, M | 3 |
| Westin, SN | 3 |
| Madariaga, A | 1 |
| Goodwin, PJ | 1 |
| Oza, AM | 1 |
1 review available for letrozole and Genital Neoplasms, Female
| Article | Year |
|---|---|
Targeting the PI3K Pathway in Gynecologic Malignancies.
Topics: Endometrial Neoplasms; Everolimus; Female; Genital Neoplasms, Female; Humans; Letrozole; Phosphatidy | 2022 |
Targeting the PI3K Pathway in Gynecologic Malignancies.
Topics: Endometrial Neoplasms; Everolimus; Female; Genital Neoplasms, Female; Humans; Letrozole; Phosphatidy | 2022 |
Targeting the PI3K Pathway in Gynecologic Malignancies.
Topics: Endometrial Neoplasms; Everolimus; Female; Genital Neoplasms, Female; Humans; Letrozole; Phosphatidy | 2022 |
Targeting the PI3K Pathway in Gynecologic Malignancies.
Topics: Endometrial Neoplasms; Everolimus; Female; Genital Neoplasms, Female; Humans; Letrozole; Phosphatidy | 2022 |
Targeting the PI3K Pathway in Gynecologic Malignancies.
Topics: Endometrial Neoplasms; Everolimus; Female; Genital Neoplasms, Female; Humans; Letrozole; Phosphatidy | 2022 |
Targeting the PI3K Pathway in Gynecologic Malignancies.
Topics: Endometrial Neoplasms; Everolimus; Female; Genital Neoplasms, Female; Humans; Letrozole; Phosphatidy | 2022 |
Targeting the PI3K Pathway in Gynecologic Malignancies.
Topics: Endometrial Neoplasms; Everolimus; Female; Genital Neoplasms, Female; Humans; Letrozole; Phosphatidy | 2022 |
Targeting the PI3K Pathway in Gynecologic Malignancies.
Topics: Endometrial Neoplasms; Everolimus; Female; Genital Neoplasms, Female; Humans; Letrozole; Phosphatidy | 2022 |
Targeting the PI3K Pathway in Gynecologic Malignancies.
Topics: Endometrial Neoplasms; Everolimus; Female; Genital Neoplasms, Female; Humans; Letrozole; Phosphatidy | 2022 |
1 other study available for letrozole and Genital Neoplasms, Female
| Article | Year |
|---|---|
Metformin in Gynecologic Cancers: Opening a New Window for Prevention and Treatment?
Topics: Diabetes Mellitus, Type 2; Everolimus; Female; Genital Neoplasms, Female; Humans; Letrozole; Metform | 2020 |